Newsroom

Categories: Drug Discovery & Development, Pharma, Corporate, Finance & Investor

Synexa Life Sciences joins CEPI in advancing global epidemic preparedness and response

May 30, 2023

Categories: Drug Discovery & Development, Pharma, Corporate, Finance & Investor

Oncodesign Services and Veritas In Silico enter into business cooperation on developing mRNA-targeted small molecule drugs

May 24, 2023

Categories: Drug Discovery & Development, Pharma, Corporate, Finance & Investor

Exothera Nucleic Acids strengthens team with industry expert

May 9, 2023

Categories: Biotechnology, Pharma, Corporate, Finance & Investor

Exothera announces a strategic partnership with Quantoom Biosciences and launches a new business unit for the development and production of RNA

April 26, 2023

Categories: Biomanufacturing, Pharma, Corporate, Finance & Investor

New Lonza Webinar — “Taking the Leap into an MES from a CEO’s Perspective”

April 20, 2023

Categories: Healthcare, Pharma, Corporate, Finance & Investor

Tillotts Pharma AG announces the launch of Octasa® 1600 mg Tablets in Canada

April 6, 2023

Categories: Biotechnology, Pharma, Corporate, Finance & Investor

Remedium and Exothera partner on scale-up and demonstration runs for AAV2-FGF18

March 22, 2023

Categories: Drug Discovery & Development, Pharma, Corporate, Finance & Investor

NDA Group welcomes Marianne Scheel Fjording, Ph.D. to the NDA Advisory Board adding essential expertise in bioanalysis and immunogenicity assessment to the team

March 7, 2023

Categories: Biotechnology, Computing & Technology, Pharma

pharma& chooses Generis’ CARA Life Sciences Platform to become the basis of its Regulatory, Quality and Legal Management System

February 22, 2023